Lief Labs Revenue and Competitors

Location

#8946

Growjo Ranking

Health

Industry

Estimated Revenue & Valuation

  • Lief Labs's estimated annual revenue is currently $28.6M per year.(i)
  • Lief Labs's estimated revenue per employee is $270,000

Employee Data

  • Lief Labs has 106 Employees.(i)
  • Lief Labs grew their employee count by 7% last year.

Lief Labs's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$14.3M599%N/AN/A
#2
$179.6M5327%N/AN/A
#3
$6.5M303%N/AN/A
#4
$5.3M28-3%N/AN/A
#5
$12.4M5128%N/AN/A
#6
$13.6M56-10%N/AN/A
#7
$6.5M30-12%N/AN/A
#8
$18M746%N/AN/A
#9
$10.2M472%N/AN/A
#10
$181.6M53813%N/AN/A
Add Company

What Is Lief Labs?

Lief Labs is a premier formulation and product development innovator and manufacturer of dietary supplements. Our in-house Product Development and R&D Team creates the best tasting and most cutting edge formulations for your dietary supplement needs. Lief also houses a state of the art, full-service **cGMP** manufacturing facility, which offers custom solutions for a multitude of dietary supplement categories. At Lief we have the industry knowledge and vision that allows us to stay ahead of trends and recognize opportunities for collaborations with entrepreneurial firms to help them build premier brands that stay relevant well beyond product expiration dates. Liefᅢᄁ¬ツᆲᅨワs turnkey solutions provide the ability to streamline operations which integrates with our customers to engage in a seamless partnership that helps brands with scalability, regulations and sustainable growth. With over 15+ years of experience in supplement manufacturing, we offer a wide range of categories that can meet or exceed the national brand standards. **Current Good Manufacturing Practice**

keywords:N/A

N/A

Total Funding

106

Number of Employees

$28.6M

Revenue (est)

7%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$22.5M10719%N/A
#2
$15.5M107-8%N/A
#3
N/A1086%N/A
#4
N/A1096%N/A
#5
$7.5M1155%N/A